TransCode Therapeutics, Inc.
RNAZ
$6.73
-$0.27-3.86%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 206.54% | 51.18% | 119.84% | 135.45% | 109.97% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -7.10% | -10.05% | -7.44% | -33.38% | -37.50% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 208.44% | 2.76% | -35.74% | -36.52% | -17.56% |
| Total Current Assets | 209.92% | 31.51% | 87.89% | 94.29% | 59.21% |
|
|
|||||
| Total Current Assets | 209.92% | 31.51% | 87.89% | 94.29% | 59.21% |
| Net Property, Plant & Equipment | 315.12% | -90.60% | -92.43% | -91.80% | -85.18% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 307.24% | -- | 0.00% | 0.00% |
| Total Assets | 2,126.32% | 32.79% | 71.34% | 80.98% | 41.10% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 29.03% | 39.24% | -52.22% | 6.04% | -11.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -90.71% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -6.27% |
| Total Other Current Liabilities | -- | -- | -- | -- | -6.27% |
| Total Current Liabilities | 26.06% | 29.94% | -55.32% | -7.26% | -20.59% |
|
|
|||||
| Total Current Liabilities | 26.06% | 29.94% | -55.32% | -7.26% | -20.59% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 7.39% | -- | -- | -- | -- |
| Total Liabilities | 12.94% | 66.41% | -39.51% | 7.22% | 163.91% |
|
|
|||||
| Common Stock & APIC | 76.84% | 45.73% | 52.36% | 57.53% | 27.31% |
| Retained Earnings | -54.84% | -47.44% | -44.84% | -51.35% | -36.16% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 611.99% | -13.69% | 364.92% | 124.52% | -223.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 611.99% | -13.69% | 364.92% | 124.52% | -223.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7,623.65% | -13.69% | 364.92% | 124.52% | -223.03% |
|
|
|||||